Associations between immigrant status and pharmacological treatments for diabetes in U.S. adults.

• DOI: 10.1037/hea0000552
• Publication Date: 2017-10-10T18:33:04Z
• Authors: Loretta Hsueh; Elizabeth A. Vrany; Jay S. Patel; Nicole A. Holling...; Adam T. Hirsh; Mary de Groot; Jesse C. Stewart
• Keywords: Male; hypoglycemic agents; emigrants and immigrants; Emigrants and Immigrants; Middle Aged; United States; 3. Good health; 03 medical and health sciences; diabetes mellitus; Diabetes Mellitus; Humans; Female; Healthcare Disparities; 0305 other medical science

Objectives: Although treatment disparities in diabetes have been documented along racial/ethnic lines, it is unclear if immigrant groups the U.S. experience similar disparities.Our primary objective was to determine whether status associated with differences pharmacological of a nationally representative sample adults diabetes.We were specifically interested oral hypoglycemic agents (OHA) and insulin.Methods: Respondents 2,260 from NHANES 2003-2012 self-reported diagnosis.Immigrant indicated by birth within (U.S.born) or outside (foreign-born) 50 States Washington, D.C. Multinomial logistic regression analyses examined associations between (a) withOHAs only (b) insulin OHA combination therapy, using no as reference group.Results: Immigrant insulin, but not OHAs, for diabetes.Adjusting demographics, severity duration, CVD, CVD risk factors, being foreign-born versus U.S.-born OHAs (OR=1.59;95% CI: 0.97-2.60).However, decreased odds (OR=0.53;95% 0.28-0.99) insulin.Conclusions: Pharmacological differs lines.To understand these findings, studies capturing processes underlying among immigrants are needed.Findings also raise possibility that integrating information about patient's status, addition identity, may be an important component culturally sensitive care.